Real-time enrollment status for this t-cell acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:36 PM UTC
| NCT Number | NCT05289687 |
| Recruiting Status | Recruiting |
| Condition | T-cell Acute Lymphoblastic Leukemia |
| Phase | PHASE2 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Eastern Cooperative Oncology Group |
| Last Updated on CT.gov | September 15, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT05289687 is currently recruiting participants. This phase2 study for t-cell acute lymphoblastic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by Eastern Cooperative Oncology Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05289687 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05289687 was last updated 3 weeks ago (September 15, 2026). HelloStudys verifies this status automatically.